Showing 1521-1530 of 2494 results for "".
- Omeros’ Omidria Receives Product-Specific J-Code from CMShttps://modernod.com/news/omeros-omidria-receives-product-specific-j-code-from-cms/2476766/Omeros announced that the Centers for Medicare and Medicaid Services (CMS) confirmed its preliminary decision to assign a permanent product-specific Healthcare Common Procedure Coding System (HCPCS) J-code for Omidria (phenylephrine and ketorolac intraocular solution) 1% / 0.3%. Omidria is
- New CPT Code for Automated Point-of-Care Retinal Imaginghttps://modernod.com/news/new-cpt-code-for-automated-point-of-care-retinal-imaging/2476690/Artificial intelligence diagnostics company IDx announced that the American Medical Association (AMA) has accepted a new category 1 CPT code for automated point-of-care retinal imaging. This new code, submitted by the American Academy of Ophthalmology (AAO) with the support of IDx, facilitates co
- EyePoint Pharmaceuticals Announces Assignment of Permanent J-Code for Dexycu by CMShttps://modernod.com/news/eyepoint-pharmaceuticals-announces-assignment-of-permanent-j-code-for-dexycu-by-the-center-for-medicare-and-medicaid-services-cms/2479679/EyePoint Pharmaceuticals announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a specific and permanent reimbursement J-code through the Healthcare Common Procedure Coding System (HCPCS) for Dexycu (dexamethasone intraocular suspension) 9%. Dexycu is the first and only
- Schwind Celebrates 30 Years in Refractive Corneal Surgeryhttps://modernod.com/news/schwind-celebrates-30-years-in-refractive-corneal-surgery/2480804/In 2022, Schwind eye-tech-solutions is celebrating a milestone, as the company marks 30 years of driving solutions for refractive corneal surgery. During this period, Schwind has expanded its treatment options for eye surgeons and patients. Founded in 1958 and initially a successful one-stop supp
- Sight Sciences Announces $30 Million Financinghttps://modernod.com/news/sight-sciences-announces-30-million-financing/2477405/Sight Sciences announced the closing of an over $30 million Series E Preferred Stock financing round led by D1 Capital Partners. Proceeds will be used for continued clinical and operational development and to support commercial expansion for Sight Sciences’ OMN
- Pfizer to Combine Upjohn Off-Patent Drug Business With Mylan Into New Companyhttps://modernod.com/news/pfizer-to-combine-upjohn-off-patent-drug-business-with-mylan-into-new-company/2476776/Pfizer plans to combine its Upjohn off-patent branded and generic established medicines business with Mylan into a new company, the drugmakers announced Monday, confirming a recent report on the matter. Under the all-stock transaction, which has been unanimously approved by the boards of both com
- Glaucoma Research Foundation Kicks off the Catalyst for a Cure Vision Restoration Initiativehttps://modernod.com/news/glaucoma-research-foundation-kicks-off-the-catalyst-for-a-cure-vision-restoration-initiative/2476588/Glaucoma Research Foundation has launched the third phase of its collaborative research program, Catalyst for a Cure. Called “The Catalyst for a Cure Vision Restoration Initiative,” the new phase was kicked off at the organization’s 2019 Annual Dinner on April 23 in San Francisco. The Cata
- Presbia Abandons Flexivue Microlens, Lays Off All But 3https://modernod.com/news/presbia-abandons-flexivue-microlens-lays-off-all-but-3/2476501/Presbia said it spiked its Flexivue microlens development program in the face of FDA headwinds, laying off all but three of its employees as it seeks investors to bail it out, according to a Mass Device report. Earlier this month, the Irvine, Calif.-based company
- Novartis Plans for Alcon Spin-Off on April 9, 2019https://modernod.com/news/novartis-plans-for-alcon-spin-off-on-april-9-2019/2476408/Novartis confirmed that conditions needed for the 100% spin-off of the Alcon eye care business have been met, and the spinoff is expected to be completed on April 9, 2019. Each Novartis shareholder will receive 1 Alcon share for every 5 Novartis shares/American Deposit
- Older Drivers in UK Are Being Forced Off the Road as the NHS Rations Cataract Operations, Campaigners Warnhttps://modernod.com/news/older-drivers-in-uk-are-being-forced-off-the-road-as-the-nhs-rations-cataract-operations-campaigners-warn/2476481/Older drivers in the UK are being forced off the road by NHS cost-cutting that has resulted in the rationing of cataract treatment, according to a